ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Volume 1781, Issue 8, August 2008, Pages 367-375
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (657 K)

  E-mail Article   
  Add to my Quick Links   
Bookmark and share in 2collab (opens in new window)
Request permission to reuse this article
  Cited By in Scopus (0)
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.bbalip.2008.05.006    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2008 Elsevier B.V. All rights reserved.

Lipolysis of the semi-solid self-emulsifying excipient Gelucire® 44/14 by digestive lipases

Sylvie Fernandeza, b, Jean-David Rodierb, Nicolas Ritterb, Bruno Mahlerb, Frédéric Demarneb, Frédéric Carrièrea, Corresponding Author Contact Information, E-mail The Corresponding Author and Vincent Janninb

aLaboratoire d'Enzymologie Interfaciale et de Physiologie de la Lipolyse, CNRS UPR 9025, 31 chemin Joseph Aiguier, 13402 Marseille cedex 20, France bGattefossé SAS, 36 chemin de Genas, 69804 Saint-Priest, France

Received 11 January 2008; 
revised 19 May 2008; 
accepted 20 May 2008. 
Available online 3 June 2008.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

Gelucire® 44/14 is a semi-solid self-emulsifying excipient used for the oral delivery of poorly water-soluble drugs. It is composed of C8-C18 acylglycerols and PEG-32 esters, all of which are potential substrates for digestive lipases. Here we studied the lipolysis of Gelucire® 44/14 by porcine pancreatic extracts, human pancreatic juice and several purified digestive lipases. Human pancreatic lipase (HPL), the main lipase involved in the digestion of triacylglycerols, did not show any significant activity on Gelucire® 44/14 or on either of its individual compounds, C8-C18 acylglycerols and PEG-32 esters. Other pancreatic lipases such as human pancreatic lipase-related protein 2 (HPLRP2) showed low activity on Gelucire® 44/14 although the highest activity of HPLRP2 was that observed on the C8-C18 acylglycerol fraction, which accounts for 20% (w/w) of Gelucire® 44/14. In addition, HPLRP2 showed low activities on the PEG-32 esters, whether these were tested individually or mixed together. Carboxyl ester hydrolase (CEH) showed high activity on Gelucire® 44/14, and the highest activities of CEH were those recorded on the total PEG-32 ester fraction and on each individual PEG-32 ester, except for PEG-32 monostearate. The highest activity of all the enzymes tested was that of dog gastric lipase (DGL) on Gelucire® 44/14, although DGL showed low activity on the PEG-32 ester fraction and on each individual PEG-32 ester. We compared the lipolysis of Gelucire® 44/14 with that of Labrasol®, another self-emulsifying excipient, which is liquid at room temperature. Human pancreatic juice showed similar rates of activity on both Gelucire® 44/14 and Labrasol®. This finding means that these excipients are hydrolyzed in vivo during pancreatic digestion, mainly by CEH in the case of Gelucire® 44/14 and by both HPLRP2 and CEH in that of Labrasol®, whereas HPL showed very low activities on each of these two excipients. This is the first time the effects of PEG and acyl chain length on the lipolytic activity of digestive lipases on PEG esters have been investigated.

Keywords: Lipase; Lipolysis; Macrogolglycerides; Oral drug delivery; Semi-solid excipient, PEG esters

Article Outline

1. Introduction
2. Materials and methods
2.1. Chemicals
2.2. Enzymes
2.3. Preparation of semi-solid samples
2.4. Determination of lipase activity on Gelucire® 44/14
2.5. Measurement of lipase specific activities on Gelucire® 44/14 compounds and PEG-‑8 and PEG-‑20 esters at pH 6.0
3. Results
3.1. Lipolysis of Gelucire® 44/14 by digestive lipases
3.1.1. Lipolysis by porcine pancreatic extracts and human pancreatic juice
3.1.2. Lipolysis by purified digestive lipases
3.1.3. Assessment of the extent of FFA ionization during Gelucire® 44/14 lipolysis and determination of the correction factor for direct activity assays
3.2. Substrate specificities of digestive lipases on Gelucire® 44/14 compounds
3.2.1. Lipolysis of acylglycerol and PEG ester fractions
3.2.2. Substrate specificities of digestive lipases on acylglycerols with various acyl chain lengths
3.2.3. Substrate specificities of digestive lipases on individual PEG-32 esters with various acyl chain lengths
3.3. Substrate specificities of digestive lipases on PEG caprylates with various PEG moieties
4. Discussion
4.1. Identification of digestive lipases acting on Gelucire® 44/14
4.2. Identification of the substrates hydrolyzed by digestive lipases during Gelucire® 44/14 lipolysis
4.3. Comparisons between Gelucire® 44/14 and Labrasol® lipolysis by digestive lipases
4.4. Effects of PEG length on lipase activities
4.5. General conclusion
Acknowledgements
References







 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.